Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Daniel Faga
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
immunology
antibody therapeutics |
| gptkbp:foundedYear |
2005
|
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
AnaptysBio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
ANB032
imsidolimab rosnilimab |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ANAB
|
| gptkbp:website |
https://www.anaptysbio.com/
|
| gptkbp:bfsParent |
gptkb:Baker_Bros._Advisors
|
| gptkbp:bfsLayer |
7
|